Nilotinib CAS: 641571-10-0
| Product Parameters | |
|---|---|
| Catalog No. | BA88K1 |
| CAS.RN | 641571-10-0 |
| Molecular Formula | C28H22F3N7O |
| Molecular Weight | 529.52 g/mol |
| Purity | NLT 98% |
Product Overview
Nilotinib is a highly selective BCR-ABL tyrosine kinase inhibitor widely used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). As an active pharmaceutical ingredient (API), nilotinib is suitable for all stages of drug development, process optimization, pilot-scale production, and commercial manufacturing. It possesses good chemical stability and processability, making it a key intermediate and starting material in anti-tumor drug development, meeting the pharmaceutical industry's stringent requirements for high-purity, high-quality APIs.
Applications
- Drug synthesis intermediates for anti-tumor drug development
- Raw material supply for tyrosine kinase inhibitors
- Compound library construction for pharmaceutical R&D institutions
- Starting materials for process route optimization and scale-up production
- Customized batch production for formulation development
Quality & Supply Capability
English Name: Nilotinib Properties: This product is a white to off-white crystalline powder with good thermal and chemical stability. Its core functional group is a quinazoline ring structure, meeting the quality standards for antitumor drug raw materials. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical team to provide customers with comprehensive technical support from laboratory R&D to industrial production, helping customers efficiently advance process development, route optimization, and project transformation.
Why Choose Bioncan
Focused on the field of anti-tumor active pharmaceutical ingredients, with extensive experience in supplying nilotinib. Full-scale supply capabilities covering needs from laboratory to commercial production. Provides complete quality control documentation to ensure product quality compliance and controllability. Supports customized needs, adjusting purity, impurity limits, and packaging according to customer requirements. Provides supporting process optimization and project scale-up technologies to improve customer R&D efficiency and production conversion rates.
Intermediates of Nilotinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA88K1 | Nilotinib API | 641571-10-0 |
| BK52Z7 | 3-(dimethylamino)-1-(PyridIN-3-yl)prop-2-en-1-one | 55314-16-4 |
| BK53NW | 4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzoic acid | 641569-94-0 |
| BK67VK | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 641571-11-1 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 641571-10-0, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.